On July 31, 2026, Yuexin Health released its 2026 interim report. The company's total operating revenue was 509 million yuan, net profit attributable to the parent was 5.331 million yuan, and net cash outflow from operating activities was 14.1128 million yuan, a decrease of 6.1709 million yuan compared to the same period last year. The company's latest asset-liability ratio was 56.86 percent, up 0.65 percentage points from the previous quarter; gross margin was 25.36 percent, down 1.13 percentage points from the previous quarter; ROE was 0.64 percent; diluted earnings per share was 0.01 yuan. Total asset turnover was 0.26 times, and inventory turnover was 2.75 times. The number of shareholders was 50,300, and the top ten shareholders held 527 million shares, accounting for 57.33 percent of the total share capital.
Everjoy Health Group Co LtdNet profit attributable to parent is only 5.331 million yuan, with operating cash flow negative and declining, indicating weak profitability and cash generation.